Literature DB >> 18772365

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.

Laura H Tetri1, Metin Basaranoglu, Elizabeth M Brunt, Lisa M Yerian, Brent A Neuschwander-Tetri.   

Abstract

The aims of this study were to determine whether combining features of a western lifestyle in mice with trans fats in a high-fat diet, high-fructose corn syrup in the water, and interventions designed to promote sedentary behavior would cause the hepatic histopathological and metabolic abnormalities that characterize nonalcoholic steatohepatitis (NASH). Male C57BL/6 mice fed ad libitum high-fat chow containing trans fats (partially hydrogenated vegetable oil) and relevant amounts of a high-fructose corn syrup (HFCS) equivalent for 1-16 wk were compared with mice fed standard chow or mice with trans fats or HFCS omitted. Cage racks were removed from western diet mice to promote sedentary behavior. By 16 wk, trans fat-fed mice became obese and developed severe hepatic steatosis with associated necroinflammatory changes. Plasma alanine aminotransferase levels increased, as did liver TNF-alpha and procollagen mRNA, indicating an inflammatory and profibrogenic response to injury. Glucose intolerance and impaired fasting glucose developed within 2 and 4 wk, respectively. Plasma insulin, resistin, and leptin levels increased in a profile similar to that seen in patients with NASH. The individual components of this diet contributed to the phenotype independently; isocaloric replacement of trans fats with lard established that trans fats played a major role in promoting hepatic steatosis and injury, whereas inclusion of HFCS promoted food consumption, obesity, and impaired insulin sensitivity. Combining risk factors for the metabolic syndrome by feeding mice trans fats and HFCS induced histological features of NASH in the context of a metabolic profile similar to patients with this disease. Because dietary trans fats promoted liver steatosis and injury, their role in the epidemic of NASH needs further evaluation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772365      PMCID: PMC4059366          DOI: 10.1152/ajpgi.90272.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  41 in total

1.  High levels of industrially produced trans fat in popular fast foods.

Authors:  Steen Stender; Jørn Dyerberg; Arne Astrup
Journal:  N Engl J Med       Date:  2006-04-13       Impact factor: 91.245

2.  Hepatotoxicity of fast food?

Authors:  Giulio Marchesini; Valentina Ridolfi; Valentina Nepoti
Journal:  Gut       Date:  2008-05       Impact factor: 23.059

Review 3.  Animal models of steatosis.

Authors:  A Koteish; A M Diehl
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

4.  Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats.

Authors:  Ahamed Ibrahim; Saravanan Natrajan; Reddy Ghafoorunissa
Journal:  Metabolism       Date:  2005-02       Impact factor: 8.694

5.  Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein.

Authors:  Benny Hung-Junn Chang; Lan Li; Antoni Paul; Susumu Taniguchi; Vijayalakshmi Nannegari; William C Heird; Lawrence Chan
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

6.  Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice.

Authors:  Katrine Almind; C Ronald Kahn
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

7.  Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.

Authors:  L Rossetti; A Giaccari; N Barzilai; K Howard; G Sebel; M Hu
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats.

Authors:  R Scott Rector; John P Thyfault; R Tyler Morris; Matthew J Laye; Sarah J Borengasser; Frank W Booth; Jamal A Ibdah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-03       Impact factor: 4.052

Review 9.  Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

Authors:  Quentin M Anstee; Robert D Goldin
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

10.  Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects.

Authors:  S Kechagias; A Ernersson; O Dahlqvist; P Lundberg; T Lindström; F H Nystrom
Journal:  Gut       Date:  2008-02-14       Impact factor: 23.059

View more
  156 in total

1.  Nutrigenomics of hepatic steatosis in a feline model: effect of monosodium glutamate, fructose, and Trans-fat feeding.

Authors:  Kate S Collison; Marya Z Zaidi; Soad M Saleh; Nadine J Makhoul; Angela Inglis; Joey Burrows; Joseph A Araujo; Futwan A Al-Mohanna
Journal:  Genes Nutr       Date:  2011-12-06       Impact factor: 5.523

2.  Greater fructose consumption is associated with cardiometabolic risk markers and visceral adiposity in adolescents.

Authors:  Norman K Pollock; Vanessa Bundy; William Kanto; Catherine L Davis; Paul J Bernard; Haidong Zhu; Bernard Gutin; Yanbin Dong
Journal:  J Nutr       Date:  2011-12-21       Impact factor: 4.798

Review 3.  Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Metin Basaranoglu; Serra Kayacetin; Nevin Yilmaz; Ertugrul Kayacetin; Orhan Tarcin; Abdullah Sonsuz
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

4.  NASH: Thiazolidinediones for NASH--one pill doesn't fix everything.

Authors:  Brent A Neuschwander-Tetri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05       Impact factor: 46.802

5.  Challenging the rodent hegemony: a new rabbit model of nonalcoholic steatohepatitis.

Authors:  Jaideep Behari; Naga Chalasani
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

6.  Advances in hepatology: current developments in the treatment of hepatitis and hepatobiliary disease.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-12

7.  Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.

Authors:  Michael Charlton; Anuradha Krishnan; Kimberly Viker; Schuyler Sanderson; Sophie Cazanave; Andrea McConico; Howard Masuoko; Gregory Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

Review 8.  Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame.

Authors:  Samar H Ibrahim; Petra Hirsova; Harmeet Malhi; Gregory J Gores
Journal:  Dig Dis Sci       Date:  2015-12-01       Impact factor: 3.199

9.  Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.

Authors:  Daniel Cabrera; Alex Ruiz; Claudio Cabello-Verrugio; Enrique Brandan; Lisbell Estrada; Margarita Pizarro; Nancy Solis; Javiera Torres; Francisco Barrera; Marco Arrese
Journal:  Dig Dis Sci       Date:  2016-08-29       Impact factor: 3.199

Review 10.  Implications of diet on nonalcoholic fatty liver disease.

Authors:  Shelby Sullivan
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.